ArticleScientific reports2025

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer.

Atefeh Ghahremanloo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.